Institut Pasteur, IP, Paris, France

Tasks in the project:
IP will contribute to work packages 1,2,4,5 and 6
WP1 : Cell culture-based discovery of antiviral inhibitors and their mechanism of action
WP2 : Antiviral targets in complex with RNA and inhibitors
WP4 : ADME-Tox and validation in animal models
WP5 : Exploitation and route-to-market
WP6 : Coordination

  Human resources

  • Dr Hervé Bourhy, DVM, PhD, PI, (M), expertise in management of research program, molecular biology,virology, epidemiology, emerging and re-emerging infection, zoonosis.
  • Dr Olivier Delmas, PhD, (M), expertise in biochemistry, cellular and molecular biology, virology.
  • Miss Rachel Lavenir (F) and M. Pascal Cozette (M), responsible for maintenance of facilities and animals,including monitoring their condition

Institut Pasteur,
28 rue du Docteur Roux,
F-75724 Paris Cedex 15.
Tél : +33 (0) 1 45 68 87 85.

The research leading to these results has received funding from the European Union Seventh Programme (FP7 2007/2013) under grant agreement n°260644-SILVER